Pathology of hypersensitivity pneumonitis (HP) Source: International Congress 2017 – Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management Year: 2017
Small airways structural alterations in usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hypersensitivity pneumonia (HP) and chronic bronchiolitis (CB) Source: Eur Respir J 2006; 28: Suppl. 50, 308s Year: 2006
Treatment of hypersensitivity pneumonitis (HP) - targeting pathways of inflammation and fibrosis Source: International Congress 2017 – Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management Year: 2017
Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – ILDs: clinical problems Year: 2017
Elevated apoptosis rate of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonitis (NSIP) – strong positive correlation with bronchoalvoelar lavage (BAL) neutrophil count. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020
Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP) Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006
Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009
Pathogenisis of hypersensitivity pneumonitis (HP) - current concepts Source: International Congress 2017 – Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management Year: 2017
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias) Source: ERS Course 2016 Year: 2016
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias) Source: ERS Courses: Interstitial Lung Diseases Year: 2019
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018
Chronic hypersensitivity pneumonitis and its differential diagnosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189 Year: 2007
Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum pseudomonas aeruginosa (Pa ) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE) Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011
Pulmonary lymphoid hyperplasia (PLH) / lymphoid interstitial pneumonitis (LIP) complex in HIV-1 infected Brazilian children: associations and prognosis Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008
Safety of sputum induction (SI) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007
CT features of fibrosing alveolitis in rheumatoid arthritis (FARA): a comparison with idiopathic usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP) Source: Eur Respir J 2003; 22: Suppl. 45, 197s Year: 2003
Pulmonary alveolar proteinosis (PAP) in exogenous toxic alveolitis (ETA) patients Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015
Massive apoptosis of alveolar lymphocytes (AL) in the course of pulmonary sarcoidosis (PS) as a predictor of disease remission Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005